Weighing in on glucagon-like peptide-1 receptor agonists in dermatology

J Am Acad Dermatol. 2024 Jul;91(1):29-30. doi: 10.1016/j.jaad.2024.04.044. Epub 2024 Apr 30.

Author

Warren R Heymann¹

Affiliation

¹ Division of Dermatology, Cooper Medical School of Rowan University, Camden, New Jersey. Electronic address: wrheymann@gmail.com.

PMID: 38692437
DOI: 10.1016/j.jaad.2024.04.044

No abstract available

Keywords: glucagon-like peptide-1 receptor agonists; semaglutide; tirzepatide.

Publication types

Editorial

MeSH terms

Dermatology
Glucagon-Like Peptide-1 Receptor Agonists* / adverse effects
Glucagon-Like Peptide-1 Receptor Agonists* / therapeutic use
Humans
Hypoglycemic Agents* / adverse effects
Hypoglycemic Agents* / therapeutic use
Skin Diseases / drug therapy

Substances

Glucagon-Like Peptide-1 Receptor Agonists
Hypoglycemic Agents